AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Fundamental Analysis

NASDAQ:AVAH • US05356F1057

7.21 USD
+0.15 (+2.12%)
At close: Feb 25, 2026
7.21 USD
0 (0%)
After Hours: 2/25/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

AVAH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AVAH while its profitability can be described as average. AVAH may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • AVAH had positive earnings in the past year.
  • AVAH had a positive operating cash flow in the past year.
  • AVAH had negative earnings in each of the past 5 years.
  • In multiple years AVAH reported negative operating cash flow during the last 5 years.
AVAH Yearly Net Income VS EBIT VS OCF VS FCFAVAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • AVAH has a better Return On Assets (4.17%) than 72.28% of its industry peers.
  • AVAH has a better Return On Equity (761.17%) than 99.01% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.25%, AVAH belongs to the best of the industry, outperforming 89.11% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AVAH is below the industry average of 8.93%.
  • The last Return On Invested Capital (13.25%) for AVAH is above the 3 year average (5.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.17%
ROE 761.17%
ROIC 13.25%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
AVAH Yearly ROA, ROE, ROICAVAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.29%, AVAH is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
  • With a decent Operating Margin value of 10.25%, AVAH is doing good in the industry, outperforming 79.21% of the companies in the same industry.
  • AVAH's Operating Margin has improved in the last couple of years.
  • The Gross Margin of AVAH (33.57%) is better than 65.35% of its industry peers.
  • AVAH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.25%
PM (TTM) 3.29%
GM 33.57%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
AVAH Yearly Profit, Operating, Gross MarginsAVAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AVAH is still creating some value.
  • AVAH has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AVAH has more shares outstanding
  • Compared to 1 year ago, AVAH has an improved debt to assets ratio.
AVAH Yearly Shares OutstandingAVAH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
AVAH Yearly Total Debt VS Total AssetsAVAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • AVAH has an Altman-Z score of 1.22. This is a bad value and indicates that AVAH is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AVAH (1.22) is worse than 63.37% of its industry peers.
  • AVAH has a debt to FCF ratio of 17.78. This is a negative value and a sign of low solvency as AVAH would need 17.78 years to pay back of all of its debts.
  • AVAH's Debt to FCF ratio of 17.78 is in line compared to the rest of the industry. AVAH outperforms 41.58% of its industry peers.
  • A Debt/Equity ratio of 130.05 is on the high side and indicates that AVAH has dependencies on debt financing.
  • AVAH has a Debt to Equity ratio of 130.05. This is amonst the worse of the industry: AVAH underperforms 82.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 130.05
Debt/FCF 17.78
Altman-Z 1.22
ROIC/WACC1.35
WACC9.84%
AVAH Yearly LT Debt VS Equity VS FCFAVAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • AVAH has a Current Ratio of 1.23. This is a normal value and indicates that AVAH is financially healthy and should not expect problems in meeting its short term obligations.
  • AVAH's Current ratio of 1.23 is in line compared to the rest of the industry. AVAH outperforms 45.54% of its industry peers.
  • A Quick Ratio of 1.23 indicates that AVAH should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.23, AVAH perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
AVAH Yearly Current Assets VS Current LiabilitesAVAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • AVAH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2500.00%, which is quite impressive.
  • AVAH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -49.58% yearly.
  • AVAH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.48%.
  • AVAH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
Revenue 1Y (TTM)15.48%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%

3.2 Future

  • AVAH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 100.99% yearly.
  • Based on estimates for the next years, AVAH will show a quite strong growth in Revenue. The Revenue will grow by 8.86% on average per year.
EPS Next Y1073%
EPS Next 2Y251.18%
EPS Next 3Y139.23%
EPS Next 5Y100.99%
Revenue Next Year20.65%
Revenue Next 2Y13.07%
Revenue Next 3Y10.5%
Revenue Next 5Y8.86%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AVAH Yearly Revenue VS EstimatesAVAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AVAH Yearly EPS VS EstimatesAVAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.02 indicates a correct valuation of AVAH.
  • Compared to the rest of the industry, the Price/Earnings ratio of AVAH indicates a rather cheap valuation: AVAH is cheaper than 81.19% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.05, AVAH is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 11.69 indicates a reasonable valuation of AVAH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AVAH indicates a rather cheap valuation: AVAH is cheaper than 84.16% of the companies listed in the same industry.
  • AVAH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.03.
Industry RankSector Rank
PE 15.02
Fwd PE 11.69
AVAH Price Earnings VS Forward Price EarningsAVAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AVAH indicates a somewhat cheap valuation: AVAH is cheaper than 67.33% of the companies listed in the same industry.
  • AVAH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AVAH is cheaper than 69.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.25
EV/EBITDA 12.32
AVAH Per share dataAVAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of AVAH may justify a higher PE ratio.
  • A more expensive valuation may be justified as AVAH's earnings are expected to grow with 139.23% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y251.18%
EPS Next 3Y139.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AVAH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVEANNA HEALTHCARE HOLDINGS

NASDAQ:AVAH (2/25/2026, 8:00:01 PM)

After market: 7.21 0 (0%)

7.21

+0.15 (+2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners23.38%
Inst Owner Change0.32%
Ins Owners5.67%
Ins Owner Change5.24%
Market Cap1.51B
Revenue(TTM)2.29B
Net Income(TTM)75.46M
Analysts77.65
Price Target11.33 (57.14%)
Short Float %8.14%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)232.09%
Min EPS beat(2)51.78%
Max EPS beat(2)412.4%
EPS beat(4)4
Avg EPS beat(4)2370.21%
Min EPS beat(4)51.78%
Max EPS beat(4)6955.89%
EPS beat(8)8
Avg EPS beat(8)1242.78%
EPS beat(12)10
Avg EPS beat(12)826.72%
EPS beat(16)10
Avg EPS beat(16)602.5%
Revenue beat(2)2
Avg Revenue beat(2)5.46%
Min Revenue beat(2)2.96%
Max Revenue beat(2)7.96%
Revenue beat(4)4
Avg Revenue beat(4)4.95%
Min Revenue beat(4)2.02%
Max Revenue beat(4)7.96%
Revenue beat(8)7
Avg Revenue beat(8)2.57%
Revenue beat(12)10
Avg Revenue beat(12)2.07%
Revenue beat(16)11
Avg Revenue beat(16)0.9%
PT rev (1m)3.63%
PT rev (3m)5.19%
EPS NQ rev (1m)2.67%
EPS NQ rev (3m)36.11%
EPS NY rev (1m)1.23%
EPS NY rev (3m)23.57%
Revenue NQ rev (1m)0.68%
Revenue NQ rev (3m)5.49%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)3.83%
Valuation
Industry RankSector Rank
PE 15.02
Fwd PE 11.69
P/S 0.66
P/FCF 18.25
P/OCF 16.82
P/B 151.93
P/tB N/A
EV/EBITDA 12.32
EPS(TTM)0.48
EY6.66%
EPS(NY)0.62
Fwd EY8.55%
FCF(TTM)0.39
FCFY5.48%
OCF(TTM)0.43
OCFY5.94%
SpS10.96
BVpS0.05
TBVpS-5.75
PEG (NY)0.01
PEG (5Y)N/A
Graham Number0.72
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 761.17%
ROCE 16.77%
ROIC 13.25%
ROICexc 14.79%
ROICexgc 415.4%
OM 10.25%
PM (TTM) 3.29%
GM 33.57%
FCFM 3.6%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
ROICexc(3y)6.24%
ROICexc(5y)5.39%
ROICexgc(3y)148.4%
ROICexgc(5y)163.95%
ROCE(3y)7.54%
ROCE(5y)6.51%
ROICexgc growth 3Y3.46%
ROICexgc growth 5Y50.58%
ROICexc growth 3Y35.54%
ROICexc growth 5Y22.27%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
F-Score8
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 130.05
Debt/FCF 17.78
Debt/EBITDA 5.62
Cap/Depr -130.77%
Cap/Sales 0.31%
Interest Coverage 1.56
Cash Conversion 39.02%
Profit Quality 109.35%
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 1.22
F-Score8
WACC9.84%
ROIC/WACC1.35
Cap/Depr(3y)53.12%
Cap/Depr(5y)65.29%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
EPS Next Y1073%
EPS Next 2Y251.18%
EPS Next 3Y139.23%
EPS Next 5Y100.99%
Revenue 1Y (TTM)15.48%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%
Revenue Next Year20.65%
Revenue Next 2Y13.07%
Revenue Next 3Y10.5%
Revenue Next 5Y8.86%
EBIT growth 1Y90.23%
EBIT growth 3Y14.38%
EBIT growth 5Y18.06%
EBIT Next Year111.52%
EBIT Next 3Y31.81%
EBIT Next 5Y24.44%
FCF growth 1Y469.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y715.42%
OCF growth 3YN/A
OCF growth 5YN/A

AVEANNA HEALTHCARE HOLDINGS / AVAH FAQ

What is the ChartMill fundamental rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to AVAH.


What is the valuation status for AVAH stock?

ChartMill assigns a valuation rating of 8 / 10 to AVEANNA HEALTHCARE HOLDINGS (AVAH). This can be considered as Undervalued.


How profitable is AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

AVEANNA HEALTHCARE HOLDINGS (AVAH) has a profitability rating of 6 / 10.


What is the valuation of AVEANNA HEALTHCARE HOLDINGS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AVEANNA HEALTHCARE HOLDINGS (AVAH) is 15.02 and the Price/Book (PB) ratio is 151.93.


Can you provide the expected EPS growth for AVAH stock?

The Earnings per Share (EPS) of AVEANNA HEALTHCARE HOLDINGS (AVAH) is expected to grow by 1073% in the next year.